Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans J Stauss

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Current Opinion in Immunology|April 15, 2022
Editorial overview: Tumour immunology: Engineered T cell therapy of cancer: current success and future improvementsHans J Stauss
Blood|August 22, 2015
Engineered T cells can fight malignant T cellsHans J Stauss
Blood|March 11, 2017
No hiding place for BOB inside myelomaHans J Stauss
Oncotarget|February 9, 2017
Turn to TCRs when CARs failHans J Stauss
Cells|May 24, 2024
Targeted Therapy of Multiple Sclerosis: A Case for Antigen-Specific TregsYiya Zhong, Hans J Stauss
Cellular & Molecular Immunology|July 3, 2007
Enhancing immune responses for cancer therapyShao An Xue, Hans J Stauss
Blood|May 22, 2016
Optimizing T-cell receptor gene therapy for hematologic malignanciesEmma C Morris, Hans J Stauss
Best Practice & Research. Clinical Haematology|September 20, 2011
T cell gene-engineering to enhance GVT and suppress GVHDSara Ghorashian, Emma Nicholson, Hans J Stauss
Cells|December 4, 2020
TCR Gene Therapy: Challenges, Opportunities, and Future DirectionsHans J Stauss, Maxine G B Tran
Cells|July 26, 2020
Engineering CD4+ T Cells to Enhance Cancer ImmunityFrancesca Sillito, Angelika Holler, Hans J Stauss
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Current Opinion in Immunology|April 15, 2022
Editorial overview: Tumour immunology: Engineered T cell therapy of cancer: current success and future improvementsHans J Stauss
Blood|August 22, 2015
Engineered T cells can fight malignant T cellsHans J Stauss
Blood|March 11, 2017
No hiding place for BOB inside myelomaHans J Stauss
Oncotarget|February 9, 2017
Turn to TCRs when CARs failHans J Stauss
Cells|May 24, 2024
Targeted Therapy of Multiple Sclerosis: A Case for Antigen-Specific TregsYiya Zhong, Hans J Stauss
Cellular & Molecular Immunology|July 3, 2007
Enhancing immune responses for cancer therapyShao An Xue, Hans J Stauss
Blood|May 22, 2016
Optimizing T-cell receptor gene therapy for hematologic malignanciesEmma C Morris, Hans J Stauss
Best Practice & Research. Clinical Haematology|September 20, 2011
T cell gene-engineering to enhance GVT and suppress GVHDSara Ghorashian, Emma Nicholson, Hans J Stauss
Cells|December 4, 2020
TCR Gene Therapy: Challenges, Opportunities, and Future DirectionsHans J Stauss, Maxine G B Tran
Cells|July 26, 2020
Engineering CD4+ T Cells to Enhance Cancer ImmunityFrancesca Sillito, Angelika Holler, Hans J Stauss
Pageof 8